These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 24044568)
1. Defining the seriousness of proliferative vitreoretinopathy by aspiration of cytokines from the anterior chamber. Rusnak S; Vrzalova J; Hecová L; Kozova M; Topolcan O; Ricarova R Biomark Med; 2013 Oct; 7(5):759-67. PubMed ID: 24044568 [TBL] [Abstract][Full Text] [Related]
2. Anterior chamber aqueous flare is a strong predictor for proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment. Schröder S; Muether PS; Caramoy A; Hahn M; Abdel-Salam M; Diestelhorst M; Kirchhof B; Fauser S Retina; 2012 Jan; 32(1):38-42. PubMed ID: 21765375 [TBL] [Abstract][Full Text] [Related]
3. CONCENTRATIONS OF VITREAL CYTOKINES IN RHEGMATOGENOUS RETINAL DETACHMENT. Danielescu C; Zugun-Eloae F; Zlei M Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):124-9. PubMed ID: 27125084 [TBL] [Abstract][Full Text] [Related]
4. Profibrotic cytokines in aqueous humour correlate with aqueous flare in patients with rhegmatogenous retinal detachment. Hoerster R; Hermann MM; Rosentreter A; Muether PS; Kirchhof B; Fauser S Br J Ophthalmol; 2013 Apr; 97(4):450-3. PubMed ID: 23355528 [TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic isoforms of vascular endothelial growth factor predominate in subretinal fluid of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy. Ricker LJ; Dieudonné SC; Kessels AG; Rennel ES; Berendschot TT; Hendrikse F; Kijlstra A; La Heij EC Retina; 2012 Jan; 32(1):54-9. PubMed ID: 21836532 [TBL] [Abstract][Full Text] [Related]
6. Retinal detachment and proliferative vitreoretinopathy: central retinal artery blood velocities, intraocular pressure, and endothelin 1. Roldán-Pallarés M; Musa AS; Hernández-Montero J; Bravo-Llatas Sc C; Fernández-Durango R Retina; 2013 Sep; 33(8):1528-39. PubMed ID: 23974951 [TBL] [Abstract][Full Text] [Related]
7. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy. Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the molecular biologic milieu of the vitreous in proliferative vitreoretinopathy. Wladis EJ; Falk NS; Iglesias BV; Beer PM; Gosselin EJ Retina; 2013 Apr; 33(4):807-11. PubMed ID: 23222459 [TBL] [Abstract][Full Text] [Related]
9. Levels of some cytokines in subretinal fluid in proliferative vitreoretinopathy and rhegmatogenous retinal detachment. Kenarova B; Voinov L; Apostolov C; Vladimirova R; Misheva A Eur J Ophthalmol; 1997; 7(1):64-7. PubMed ID: 9101198 [TBL] [Abstract][Full Text] [Related]
10. [Relaxing peripheral retinotomy with endolaser in treatment of retinal detachment with severe anterior proliferative vitreoretinopathy]. Li X; Jiang Y Zhonghua Yan Ke Za Zhi; 1998 Nov; 34(6):411-4. PubMed ID: 11877240 [TBL] [Abstract][Full Text] [Related]
11. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy. Dieudonné SC; La Heij EC; Diederen RM; Kessels AG; Liem AT; Kijlstra A; Hendrikse F Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114 [TBL] [Abstract][Full Text] [Related]
12. [Lenticular-vitreoretinal surgery for complicated retinal detachment]. Liu W; Wang J; Chen S Zhonghua Yan Ke Za Zhi; 1997 May; 33(3):207-9. PubMed ID: 10437038 [TBL] [Abstract][Full Text] [Related]
13. Conventional retinal surgery for rhegmatogenous retinal detachment with proliferative vitreoretinopathy. Ivanisević M Acta Med Croatica; 1995; 49(4-5):207-9. PubMed ID: 8630455 [TBL] [Abstract][Full Text] [Related]
14. [Retinal detachment with anterior proliferative vitreoretinopathy and its surgical treatment]. Liu W; Wang J; Chen H Zhonghua Yan Ke Za Zhi; 2000 Sep; 36(5):351-4. PubMed ID: 11853627 [TBL] [Abstract][Full Text] [Related]
15. Substance P in proliferative vitreoretinopathy: the significance of aqueous humor levels for evolution of the disease. Troger J; Kremser B; Irschick E; Göttinger W; Kieselbach G Graefes Arch Clin Exp Ophthalmol; 1998 Dec; 236(12):900-3. PubMed ID: 9865620 [TBL] [Abstract][Full Text] [Related]
16. Intercellular adhesion molecule-1 in proliferative vitreoretinopathy. Limb GA; Chignell AH; Cole CJ; Green WT; Webster L; Hollifield RD; Dumonde DC Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1043-8. PubMed ID: 9113001 [TBL] [Abstract][Full Text] [Related]
17. Clinical results of Densiron 68 intraocular tamponade for complicated retinal detachment. Li W; Zheng Q; Wang X; Xu M; Wu R Ophthalmologica; 2010; 224(6):354-60. PubMed ID: 20453542 [TBL] [Abstract][Full Text] [Related]
18. Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy. Sethi CS; Lewis GP; Fisher SK; Leitner WP; Mann DL; Luthert PJ; Charteris DG Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):329-42. PubMed ID: 15623793 [TBL] [Abstract][Full Text] [Related]
19. [Scleral compression in assessment of the stage of proliferative vitreoretinopathy and type of subretinal contents in retinal detachment]. Il'nitskiĭ VV; Saksonova EO; Movshovich AI Vestn Oftalmol; 1994; 110(3):12-4. PubMed ID: 7810033 [TBL] [Abstract][Full Text] [Related]
20. C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy. Capeans C; De Rojas MV; Lojo S; Salorio MS Retina; 1998; 18(6):546-50. PubMed ID: 9869464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]